Close Menu
Home › Cepheid Flu/RSV Test Gets FDA Clearance, CLIA Waiver

Cepheid Flu/RSV Test Gets FDA Clearance, CLIA Waiver

Jul 26, 2018

NEW YORK (GenomeWeb) – An assay from Cepheid to detect influenza A and B as well as respiratory syncytial virus has been cleared by the US Food and Drug Administration and granted CLIA waiver, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In PCR

  1. Inflammatix Inks BARDA Contract for up to $72M

  2. T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

  3. Biocept Q3 Revenues Nearly Double

  4. Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.